During the past decade, Texas Tech University Health Sciences Center-Amarillo conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 39 clinical trials were completed, i.e. on average, 162.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 10 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Tech University Health Sciences Center-Amarillo" #1 sponsor was "Children's Oncology Group" with 62 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 3 trials sponsored and "Texas Tech University Health Sciences Center" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Tech University Health Sciences Center-Amarillo" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "Arkana Labs" with 1 trials as a collaborator, "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "EBMT Solid Tumors Working Party" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Texas Tech University Health Sciences Center-Amarillo" are "Acute Lymphoblastic Leukemia" (8 trials), "Sarcoma" (7 trials), "Leukemia" (5 trials), "Neuroblastoma" (5 trials) and "Adult Rhabdomyosarcoma" (4 trials). Many other conditions were trialed in "Texas Tech University Health Sciences Center-Amarillo" in a lesser frequency.

Most popular intervention types in "Texas Tech University Health Sciences Center-Amarillo" are "Drug" (65 trials), "Other" (45 trials), "Biological" (35 trials), "Radiation" (31 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Cyclophosphamide" (21 trials), "Vincristine Sulfate" (19 trials), "Radiation Therapy" (16 trials) and "etoposide" (14 trials). Other intervention names were less common.

The vast majority of trials in "Texas Tech University Health Sciences Center-Amarillo" are 89 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Texas Tech University Health Sciences Center-Amarillo". undefined are not yet recruiting, 14 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Texas Tech University Health Sciences Center-Amarillo, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Tech University Health Sciences Center-Amarillo, 3 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".